LYCOS RETRIEVER 
Ovulation: Women
built 633 days ago
Ovulation takes place, on average, about two weeks before your period, though it can vary from 10-16 days before the onset of menstruation depending on the length of your luteal phase. During an “average” 28 day cycle, ovulation is usually expected to take place between cycle days 13-15. Based on this guideline, many women are taught to expect ovulation around day 14 of their menstrual cycle. Many women... do not have average cycles and even those who usually do may see irregularities from time to time.
Source:
Syndrome O -- Ovarian confusion, Ovulation disruption, and Overnourishment -- reflects a novel and important approach for teaching women how closely their metabolism and fertility are linked. "More importantly, we can systematically demonstrate how women can meet their own personal Syndrome O challenges. This is accomplished through the Syndrome O Survival (SOS) Strategies," stated Dr. Feinberg, who further outlined in his talk how one's personal lifestyle and treatments should be organized and optimized.
Source:
One way to recognize when ovulation is happening is to take the body temperature with a basal thermometer (a special thermometer that will show even slight changes in body temperature) before rising in the morning. In most women, the body temperature rises slightly soon after ovulation occurs each month and does not return to normal until the menstrual flow begins. Another way is to count 14 days forward from the first day of the last menstrual period in an average 28-day cycle (count 15 days for a cycle that is normally 29 days long, 16 days for a cycle that is normally 30 days long, and so on). However, this method is less accurate than the thermometer method because the length of the menstrual cycle can vary from month to month. Some women feel abdominal cramps during ovulation.
Source:
Counting days of the cycle is by far the easiest and least technical of all of the methods for tracking ovulation. But, it is really a retrospective indicator. It can tell any woman when her last ovulation was. But, it works well as a predictor for the next ovulation in women whose cycles are very regular. If the woman has a regular cycle, then this method can work for her. For example, if she has a perfect 30-day cycle, she will ovulate on day 16 (30-14=16). Day 1 is the first day of her next period.
Source:
The goal in anovulatory women is mono-ovulation, whereas with superovulation multiple follicle development is desired. However, even in anovulatory women, the use of Clomid can result in the development of multiple follicles as the result of prolonged clearance of its isomers. Thus, the risk of multiple gestation is increased to 8%. Other side effects ... limit the usefulness of Clomid Namely; Clomid exerts undesirable anti-estrogenic effects in the periphery (endocervix, endometrium, and ovary) that helps explain the discrepancy between ovulation and conception rates. Additionally, vasomotor flushes may occur as frequently as in 10% of cycles. Other side effects include mood swings, visual disturbances, breast tenderness, pelvic discomfort, and nausea.
Source:
The Phase IIIb, prospective, open-label study was conducted at nine fertility centers in the United States and included 62 premenopausal women ages 18-40 years undergoing ovulation induction for oligoanovulatory infertility. Using the Gonal-f(R) RFF Pen, patients administered a fixed dose of recombinant follitropin alfa for 5 days followed by dose adjustment if necessary until a lead follicle reached a mean diameter >/= 14 mm. Eligible patients had undergone at least one treatment cycle of gonadotropin therapy administered with vials/ampules and syringes within the past 6 months. Patient satisfaction with prior gonadotropin therapy was measured using a pre-treatment questionnaire while patient satisfaction with the Gonal-f(R) RFF Pen was measured using an in-treatment questionnaire as well as a post-treatment interview that asked participants to compare their treatment experiences and choose a preferred injection method. The primary endpoint was the proportion of patients who preferred the Gonal-f(R) RFF Pen to vials/ampules and syringes. All patients who completed the primary endpoint (61/61, 100%) preferred the Gonal-f(R) RFF Pen. The majority of women ovulated (79%) and pregnancy was achieved in 12 women (20%).
Source:
MORE ABOUT
Women